Strong first-quarter growth for pharmaceutical and speciality ingredients player Lonza will pave the way for higher-than-expected sales growth in 2017, said the firm as it upgraded its full-year outlook.
from NutraIngredients RSS http://ift.tt/2otu5gu
via IFTTT